SCHEMBL24677007

SCHEMBL24677007

Cn1c(=O)cc(NCl)c2cc(-n3ccnc3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.42
CYP19A1 P11511 2/20 0.40
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
NOTUM Q6P988 1/20 0.39
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
HTT P42858 2/20 0.39
CYP3A4 P08684 2/20 0.38
BAZ2B Q9UIF8 1/20 0.38
CRBN Q96SW2 2/20 0.38
TBXAS1 P24557 1/20 0.38
BCL6 P41182 2/20 0.37
CNR2 P34972 1/20 0.37
CYP2D6 P10635 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24677009 0.84 IDO1 (0.48) IDO1CYP19A1PRMT5WDR77NOTUM
SCHEMBL29769796 0.80 CD38 (0.47) PRMT5WDR77PDE3BPDE3ABCL6
Hydrochloric Acid SCHEMBL29769798 0.79 CD38 (0.46) PRMT5WDR77PDE3BPDE3ABCL6
SCHEMBL29769794 0.77 CD38 (0.49) BCL6CNR2
SCHEMBL24676146 0.77 CD38 (0.49) BCL6CNR2
SCHEMBL29769775 0.77 CD38 (0.47) BCL6
SCHEMBL24676901 0.77 CNR1 (0.47) IDO1BCL6CNR2
SCHEMBL24676743 0.77 CD38 (0.47) BCL6
SCHEMBL29769785 0.77 CNR1 (0.47) IDO1BCL6CNR2
SCHEMBL24677011 0.75 CD38 (0.45) BCL6CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220242862-A1 QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220242862-A1 QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38 CD38, NQO2, NQO1 IDO1 1082/4885CYP19A1 2769/4885PRMT5 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.